HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $97 | -66.7% | 64,528 | -44.6% | 0.01% | -72.2% |
| Q4 2022 | $291 | -99.9% | 116,574 | +34.8% | 0.04% | -25.0% |
| Q3 2022 | $365,000 | -35.1% | 86,459 | -57.1% | 0.05% | -42.9% |
| Q2 2022 | $562,000 | -33.7% | 201,424 | +35.8% | 0.08% | -26.3% |
| Q1 2022 | $848,000 | +170.1% | 148,272 | +331.3% | 0.11% | +192.3% |
| Q4 2021 | $314,000 | -19.5% | 34,374 | -5.7% | 0.04% | -2.5% |
| Q3 2021 | $390,000 | -58.2% | 36,442 | -39.4% | 0.04% | -61.9% |
| Q2 2021 | $933,000 | +72.5% | 60,093 | +80.1% | 0.10% | +16.7% |
| Q1 2021 | $541,000 | -13.4% | 33,369 | -20.9% | 0.09% | -13.5% |
| Q3 2020 | $625,000 | +31.6% | 42,177 | +4.2% | 0.10% | -12.6% |
| Q1 2020 | $475,000 | -26.7% | 40,459 | +46.8% | 0.12% | +58.7% |
| Q4 2019 | $648,000 | – | 27,559 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |